Autonomous Therapeutics, Inc. is a preclinical biotechnology company founded in New York City in 2017 by inventors from Harvard Medical School and UCSF.

We are developing the therapies that evolve along with infectious diseases—to provide broad-spectrum, ‘resistance-proof’ interventions.

Imagine taking a vaccine drug once and never worrying about the flu again.